ENVB
Enveric Biosciences Inc
NASDAQ: ENVB · HEALTHCARE · BIOTECHNOLOGY
$3.95
-23.45% today
Updated 2026-04-30
Market cap
$10.01M
P/E ratio
—
P/S ratio
0.08x
EPS (TTM)
$-36.24
Dividend yield
—
52W range
$2 – $18
Volume
5.0M
Enveric Biosciences Inc (ENVB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-305907.00 | $329928.00 | $-150186.00 | $-65041.00 | $-40666.00 | $-30346.00 | $-24850.00 | $-21632.00 | $-43164.00 | $-3.67M | $-2.70M | $-2.74M | $-2.57M | $-647860.00 | $-3.89M | $-11.46M | $-17.15M | $-14.09M | $-7.73M | $-8.14M |
| Capital expenditures | $15013.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.69M | $3.69M | $4840.00 | $189719.00 | $84331.00 | $44143.00 | $864719.00 | $584165.00 | $5180.00 | $0.00 | $3.00 |
| Depreciation | $37229.00 | — | — | — | — | — | — | — | — | $157941.00 | $1.36M | $3.22M | $2.90M | $2.27M | $120872.00 | $681612.00 | $435201.00 | $408030.00 | $337489.00 | — |
| Stock-based comp | — | — | — | — | — | — | — | — | — | $141910.00 | $1.46M | $7.08M | $1.25M | $586495.00 | $1.98M | $12.60M | $2.62M | $2.15M | $1.56M | $827323.00 |
| Free cash flow | $-320920.00 | $329928.00 | $-150186.00 | $-65041.00 | $-40666.00 | $-30346.00 | $-24850.00 | $-21632.00 | $-43164.00 | $-5.36M | $-6.39M | $-2.75M | $-2.76M | $-732191.00 | $-3.93M | $-12.32M | $-17.73M | $-14.10M | $-7.73M | $-8.14M |
| Investing cash flow | $-15013.00 | $-350188.00 | $1.00M | — | — | — | — | — | — | $-1.51M | $-6.59M | $-808884.00 | $-3.64M | $-284331.00 | $-44143.00 | $2.19M | $-584165.00 | $11667.00 | — | — |
| Financing cash flow | $-773.00 | $373339.00 | $-1.36M | — | $40000.00 | $47451.00 | $8000.00 | $20500.00 | $48000.00 | $6.24M | $8.80M | $7.05M | $2.69M | $560000.00 | $5.53M | $24.90M | $18.18M | $-1.34M | $7.67M | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | $2.09B | $2.09T | — | — | — | — | — | — | $3.36M |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |